By SRH, Pfizer CEO Albert Bourla confidently acknowledges that the COVID pandemic and the successful rollout of mRNA shots were merely a stepping stone towards a much grander future. In discussing Pfizer’s prospects as a leading vaccine manufacturer, Bourla dismisses concerns that the company’s glory days are behind them now that the COVID crisis has subsided. “I firmly believe that Pfizer’s greatest achievements lie ahead of us, as COVID served as a valuable rehearsal for what is yet to come.” He goes on to proudly declare that Pfizer is now equipped to swiftly deploy mRNA shots in response to future “primary diseases.” Furthermore, Bourla emphasizes that COVID now appears trivial in comparison, as Pfizer sets its sights on conquering cancer and numerous other medical challenges in the years ahead. The rapid onset of the disease has led to experts dubbing the phenomenon…...